Genetic causes of kidney stones and kidney failure

Clinical Reviews in Bone and Mineral Metabolism

Volumn 10, Issue 1, 2012, Pages 2-18

  Beara Lasic, Lada ^a,b   Edvardsson, Vidar O ^c,d   Palsson, Runolfur ^c,d   Lieske, John C ^e   Goldfarb, David S ^a,b   Milliner, Dawn S ^e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

^e MAYO CLINIC   (United States)

Author keywords

Adenine phosphoribosyltransferase deficiency; Cystinuria; Dent disease; Dihydroxyadenine; Nephrolithiasis; Primary hyperoxaluria; Urolithiasis

Indexed keywords

2,8 DIHYDROXYADENINE; ADENINE PHOSPHORIBOSYLTRANSFERASE; ALANINE GLYOXYLATE AMINOTRANSFERASE; ALLOPURINOL; ALPHA 1 MICROGLOBULIN; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BETA 2 MICROGLOBULIN; CALCIUM OXALATE; CALCIUM PHOSPHATE; CITRIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FEBUXOSTAT; PENICILLAMINE; PROTEIN; PYRIDOXINE; SLC3A1 PROTEIN; SLC7A9 PROTEIN; THIAZIDE DIURETIC AGENT; TIOPRONIN; UNCLASSIFIED DRUG; URIC ACID;

ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY; BETA 2 MICROGLOBULIN URINE LEVEL; CALCIUM EXCRETION; CYSTINURIA; DENT DISEASE; DERMADROME; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; EOSINOPHILIA; FEVER; FLUID INTAKE; FLUID THERAPY; GENE MUTATION; GENETIC ANALYSIS; GENETICS; GLOMERULUS FILTRATION RATE; HEMATURIA; HEPATITIS; HUMAN; HYPERCALCIURIA; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER METABOLISM; MORBIDITY; NEPHROLITHIASIS; NONHUMAN; OXALOSIS 1; PATIENT COMPLIANCE; PH; PROGNOSIS; PROTEINURIA; REVIEW; SODIUM RESTRICTION; URIC ACID BLOOD LEVEL; URINALYSIS; URINARY EXCRETION; URINARY TRACT INFECTION; X CHROMOSOME;

EID: 84857782709     PISSN: 15348644     EISSN: 15590119     Source Type: Journal    
DOI: 10.1007/s12018-011-9113-7     Document Type: Review

References (105)

1. DS Goldfarb, et al. 2005 A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) registry Kidney Int 67 3 1053 1061 15698445 10.1111/j.1523-1755.2005.00170.x (Pubitemid 41623330)
2. JC Lieske, et al. 2005 International registry for primary hyperoxaluria Am J Nephrol 25 3 290 296 15961949 10.1159/000086360 (Pubitemid 41202753)
3. P Cochat, et al. 1995 Primary hyperoxaluria type 1: the therapeutic dilemma Adv Nephrol Necker Hosp 24 227 242 7572411 1:STN:280: DyaK28%2Fgtl2rug%3D%3D
4. B Hoppe BB Beck DS Milliner 2009 The primary hyperoxalurias Kidney Int 75 12 1264 1271 19225556 10.1038/ki.2009.32 1:CAS:528:DC%2BD1MXms12jtr0%3D
5. DM Cibrik, et al. 2002 Renal allograft survival in patients with oxalosis Transplantation 74 5 707 710 12352890 10.1097/00007890-200209150-00020 1:CAS:528:DC%2BD38XnsVarsLc%3D
6. EJ Bergstralh, et al. 2010 Transplantation outcomes in primary hyperoxaluria Am J Transpl 10 11 2493 2501 10.1111/j.1600-6143.2010.03271.x 1:STN:280:DC%2BC3cbjtFOiug%3D%3D
7. CS van Woerden, et al. 2003 Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome Nephrol Dial Transpl 18 2 273 279 10.1093/ndt/18.2.273 (Pubitemid 36181676)
8. R Belostotsky, et al. 2010 Mutations in DHDPSL are responsible for primary hyperoxaluria type III Am J Hum Genet 87 3 392 399 20797690 10.1016/j.ajhg.2010.07.023 1:CAS:528:DC%2BC3cXhtFamsbfN
9. E Leumann B Hoppe 2001 The primary hyperoxalurias J Am Soc Nephrol 12 9 1986 1993 11518794 1:STN:280:DC%2BD3MvnsFeqsQ%3D%3D (Pubitemid 32801376)
10. DS Milliner, et al. 1994 Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria N Engl J Med 331 23 1553 1558 7969325 10.1056/NEJM199412083312304 1:STN:280: DyaK2M%2FlvFarsA%3D%3D (Pubitemid 24366902)
11. DS Milliner DM Wilson LH Smith 2001 Phenotypic expression of primary hyperoxaluria: comparative features of types I and II Kidney Int 59 1 31 36 11135054 10.1046/j.1523-1755.2001.00462.x 1:STN:280:DC%2BD3M7jtFWqtA%3D%3D (Pubitemid 32055211)
12. B Hoppe, et al. 1999 Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure Kidney Int 56 1 268 274 10411702 10.1046/j.1523-1755.1999.00546.x 1:CAS:528:DyaK1MXksVyjsr0%3D (Pubitemid 29300544)
13. B Hoppe CB Langman 2003 A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria Pediatr Nephrol 18 10 986 991 12920626 10.1007/s00467-003-1234-x (Pubitemid 37236210)
14. DS Milliner 2005 The primary hyperoxalurias: an algorithm for diagnosis Am J Nephrol 25 2 154 160 15855742 10.1159/000085407 (Pubitemid 40864184)
15. CG Monico, et al. 2007 Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis J Am Soc Nephrol 18 6 1905 1914 17460142 10.1681/ASN.2006111230 1:CAS:528:DC%2BD2sXnt1WjsLY%3D (Pubitemid 46870327)
16. O Devuyst RV Thakker 2010 Dent's disease Orphanet J Rare Dis 5 28 20946626 10.1186/1750-1172-5-28
17. SJ Scheinman, et al. 2000 Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria Kidney Int 57 1 232 239 10620204 10.1046/j.1523-1755.2000.00774.x 1:CAS:528:DC%2BD3cXivFOlu7k%3D (Pubitemid 30227770)
18. SE Lloyd, et al. 1996 A common molecular basis for three inherited kidney stone diseases Nature 379 6564 445 449 8559248 10.1038/379445a0 1:CAS:528:DyaK28XovVagsw%3D%3D (Pubitemid 26039523)
19. RR Hoopes Jr, et al. 2005 Dent disease with mutations in OCRL1 Am J Hum Genet 76 2 260 267 15627218 10.1086/427887 1:CAS:528:DC%2BD2MXpsFejuw%3D%3D (Pubitemid 40129552)
20. M Ludwig B Utsch LA Monnens 2006 Recent advances in understanding the clinical and genetic heterogeneity of Dent's disease Nephrol Dial Transpl 21 10 2708 2717 10.1093/ndt/gfl346 (Pubitemid 44542221)
21. SC Reinhart, et al. 1995 Characterization of carrier females and affected males with X-linked recessive nephrolithiasis J Am Soc Nephrol 5 7 1451 1461 7703383 1:STN:280:DyaK2M3hvVSmtw%3D%3D
22. JB Hodgin, et al. 2008 Dent disease presenting as partial Fanconi syndrome and hypercalciuria Kidney Int 73 11 1320 1323 18235437 10.1038/sj.ki.5002785 1:STN:280:DC%2BD1czhsF2jtw%3D%3D (Pubitemid 351693143)
23. A Bokenkamp, et al. 2009 Dent-2 disease: a mild variant of Lowe syndrome J Pediatr 155 1 94 99 19559295 10.1016/j.jpeds.2009.01.049
24. SE Lloyd, et al. 1997 Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders Hum Mol Genet 6 8 1233 1239 9259268 10.1093/hmg/6.8.1233 1:CAS:528:DyaK2sXltVSms7o%3D (Pubitemid 27351062)
25. OM Wrong AG Norden TG Feest 1994 Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance QJM 87 8 473 493 7922301 1:STN:280:DyaK2M%2Fgs1KjsA%3D%3D (Pubitemid 24243467)
26. Y Frishberg, et al. 2009 Dent's disease manifesting as focal glomerulosclerosis: is it the tip of the iceberg? Pediatr Nephrol 24 12 2369 2373 19806368 10.1007/s00467-009-1299-2
27. L Copelovitch MA Nash BS Kaplan 2007 Hypothesis: Dent disease is an under recognized cause of focal glomerulosclerosis Clin J Am Soc Nephrol 2 5 914 918 17702731 10.2215/CJN.00900207 1:CAS:528:DC%2BD2sXhsVKiur3P
28. B Utsch, et al. 2006 Novel OCRL1 mutations in patients with the phenotype of Dent disease Am J Kidney Dis 48 6 942 e1 942 e14 10.1053/j.ajkd.2006.08.018 (Pubitemid 44895368)
29. RR Hoopes Jr, et al. 2004 Evidence for genetic heterogeneity in Dent's disease Kidney Int 65 5 1615 1620 15086899 10.1111/j.1523-1755.2004.00571.x 1:CAS:528:DC%2BD2cXktl2gsLs%3D (Pubitemid 38591008)
30. A Mattoo DS Goldfarb 2008 Cystinuria Semin Nephrol 28 2 181 191 18359399 10.1016/j.semnephrol.2008.01.011 1:CAS:528:DC%2BD1cXltlGqtLY%3D (Pubitemid 351400305)
31. J Chillaron, et al. 2010 Pathophysiology and treatment of cystinuria Nat Rev Nephrol 6 7 424 434 20517292 10.1038/nrneph.2010.69 1:CAS:528: DC%2BC3cXotFehtL4%3D
32. L Dello Strologo, et al. 2002 Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification J Am Soc Nephrol 13 10 2547 2553 12239244 10.1097/01.ASN.0000029586.17680.E5
33. L Dello Strologo, et al. 2007 Cystinuria in children and young adults: success of monitoring free-cystine urine levels Pediatr Nephrol 22 11 1869 1873 17694338 10.1007/s00467-007-0575-2 (Pubitemid 47506226)
34. PR Goodyer, et al. 1993 Prospective analysis and classification of patients with cystinuria identified in a newborn screening program J Pediatr 122 4 568 572 8463902 10.1016/S0022-3476(05)83537-1 1:STN:280:DyaK3s3hslOlsg%3D%3D (Pubitemid 23093581)
35. V Edvardsson, et al. 2001 Clinical features and genotype of adenine phosphoribosyltransferase deficiency in Iceland Am J Kidney Dis 38 3 473 480 11532677 10.1053/ajkd.2001.26826 1:CAS:528:DC%2BD3MXnvVOitr4%3D (Pubitemid 32803056)
36. SH Nasr, et al. 2010 Crystalline nephropathy due to 2, 8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure Nephrol Dial Transpl 25 6 1909 1915 10.1093/ndt/gfp711 1:CAS:528: DC%2BC3cXmvVWjtrg%3D
37. WN Kelley, et al. 1968 Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man J Clin Invest 47 10 2281 2289 5676523 10.1172/JCI105913 1:CAS:528:DyaF1MXpvVOl
38. P Cartier M Hamet J Hamburger 1974 A new metabolic disease: the complete deficit of adenine phosphoribosyltransferase and lithiasis of 2, 8-dihydroxyadenine C R Acad Sci Hebd Seances Acad Sci D 279 10 883 886 4219298 1:CAS:528:DyaE2MXhtV2rsrY%3D
39. HA Simmonds, et al. 1976 The identification of 2, 8-dihydroxyadenine, a new component of urinary stones Biochem J 157 2 485 487 962876 1:CAS:528:DyaE28XlslGjtbY%3D
40. A Sahota, et al. 1994 Missense mutation in the adenine phosphoribosyltransferase gene causing 2, 8-dihydroxyadenine urolithiasis Hum Mol Genet 3 5 817 818 7915931 10.1093/hmg/3.5.817 1:CAS:528:DyaK2cXktlantLg%3D (Pubitemid 24148629)
41. Y Hidaka, et al. 1987 Nucleotide sequence of the human APRT gene Nucleic Acids Res 15 21 9086 3684585 10.1093/nar/15.21.9086 1:CAS:528:DyaL1cXhsVCns70%3D
42. G Bollee, et al. 2010 Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency J Am Soc Nephrol 21 4 679 688 20150536 10.1681/ASN.2009080808 1:CAS:528:DC%2BC3cXltlWlurg%3D
43. B Benedetto, et al. 2001 Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction Am J Kidney Dis 37 5 E37 11325702 10.1016/S0272-6386(05)90001-2 1:STN:280:DC%2BD3MrlsFCitg%3D%3D
44. HA Brown 1998 Recurrence of 2, 8-dihydroxyadenine tubulointerstitial lesions in a kidney transplant recipient with a primary presentation of chronic renal failure Nephrol Dial Transpl 13 4 998 1000 10.1093/ndt/13.4.998 1:STN:280:DyaK1c3islyhsw%3D%3D (Pubitemid 28161781)
45. MJ Cassidy, et al. 2004 Diagnosis of adenine phosphoribosyltransferase deficiency as the underlying cause of renal failure in a renal transplant recipient Nephrol Dial Transpl 19 3 736 738 10.1093/ndt/gfg562 (Pubitemid 38263140)
46. DJ de Jong, et al. 1996 2, 8-Dihydroxyadenine stone formation in a renal transplant recipient due to adenine phosphoribosyltransferase deficiency J Urol 156 5 1754 1755 8863589 10.1016/S0022-5347(01)65501-0 (Pubitemid 26344035)
47. P Eller, et al. 2004 Four consecutive renal transplantations in a patient with adenine phosphoribosyltransferase deficiency Clin Nephrol 61 3 217 221 15077874 1:STN:280:DC%2BD2c7ot1agtA%3D%3D (Pubitemid 38396914)
48. ER Gagne, et al. 1994 Chronic renal failure secondary to 2, 8-dihydroxyadenine deposition: the first report of recurrence in a kidney transplant Am J Kidney Dis 24 1 104 107 8023815 1:STN:280:DyaK2c3psFGmsg%3D%3D
49. D Glicklich, et al. 1988 2, 8-dihydroxyadenine urolithiasis: report of a case first diagnosed after renal transplant QJM 68 258 785 793 3077470 1:STN:280:DyaK3c%2FkslCmsA%3D%3D (Pubitemid 19063645)
50. MH Gault, et al. 1981 Urolithiasis due to 2, 8-dihydroxyadenine in an adult N Engl J Med 305 26 1570 1572 7311997 10.1056/NEJM198112243052608 1:STN:280:DyaL38%2FotVGgtQ%3D%3D
51. T Laxdal TA Jonasson 1988 Adenine phosphoribosyltransferase deficiency in Iceland Acta Med Scand 224 6 621 626 3207073 10.1111/j.0954-6820.1988.tb19635.x 1:STN:280:DyaL1M%2Fos1agsQ%3D%3D (Pubitemid 19028207)
52. K Suzuki, et al. 1997 Family study of 2, 8-dihydroxyadenine stone formation: report of two cases of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0) Int J Urol 4 3 304 306 9255672 10.1111/j.1442-2042.1997.tb00195.x 1:STN:280: DyaK2szpvFGmtg%3D%3D (Pubitemid 127494971)
53. G Rumsby E Williams M Coulter-Mackie 2004 Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias Kidney Int 66 3 959 963 15327387 10.1111/j.1523-1755.2004.00842.x 1:CAS:528:DC%2BD2cXnvVCrt7o%3D (Pubitemid 39120998)
54. CJ Danpure 2005 Molecular etiology of primary hyperoxaluria type 1: new directions for treatment Am J Nephrol 25 3 303 310 15961951 10.1159/000086362 (Pubitemid 41202755)
55. MB Coulter-Mackie 2005 Preliminary evidence for ethnic differences in primary hyperoxaluria type 1 genotype Am J Nephrol 25 3 264 268 15961945 10.1159/000086356 (Pubitemid 41202749)
56. AJ Smith, et al. 2009 Characterization of Dent's disease mutations of CLC-5 reveals a correlation between functional and cell biological consequences and protein structure Am J Physiol Renal Physiol 296 2 F390 F397 19019917 10.1152/ajprenal.90526.2008 1:CAS:528:DC%2BD1MXitVejurc%3D
57. O Devuyst, et al. 1999 Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease Hum Mol Genet 8 2 247 257 9931332 10.1093/hmg/8.2.247 1:CAS:528:DyaK1MXht12itrY%3D (Pubitemid 29054266)
58. T Suzuki, et al. 2006 Intracellular localization of ClC chloride channels and their ability to form hetero-oligomers J Cell Physiol 206 3 792 798 16222710 10.1002/jcp.20516 1:CAS:528:DC%2BD28XhsFWhurk%3D (Pubitemid 43191054)
59. G Novarino, et al. 2010 Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis Science 328 5984 1398 1401 20430975 10.1126/science.1188070 1:CAS:528:DC%2BC3cXntVyhtbY%3D
60. LR Carraro-Lacroix, et al. 2010 Role of CFTR and ClC-5 in modulating vacuolar H+-ATPase activity in kidney proximal tubule Cell Physiol Biochem 26 4-5 563 576 21063094 10.1159/000322324 1:CAS:528:DC%2BC3cXhtl2isrbO
61. AA Reed, et al. 2010 CLC-5 and KIF3B interact to facilitate CLC-5 plasma membrane expression, endocytosis, and microtubular transport: relevance to pathophysiology of Dent's disease Am J Physiol Renal Physiol 298 2 F365 F380 19940036 10.1152/ajprenal.00038.2009 1:CAS:528:DC%2BC3cXhvVykt78%3D
62. DH Hryciw, et al. 2003 Cofilin interacts with ClC-5 and regulates albumin uptake in proximal tubule cell lines J Biol Chem 278 41 40169 40176 12904289 10.1074/jbc.M307890200 1:CAS:528:DC%2BD3sXnvFamsbc%3D (Pubitemid 37248585)
63. T Grand, et al. 2011 Heterogeneity in the processing of CLCN5 mutants related to Dent disease Hum Mutat 32 4 476 483 21305656 10.1002/humu.21467 1:CAS:528:DC%2BC3MXlslOitrk%3D
64. MA Dressman, et al. 2000 Ocrl1, a PtdIns(4, 5)P(2) 5-phosphatase, is localized to the trans-Golgi network of fibroblasts and epithelial cells J Histochem Cytochem 48 2 179 190 10639484 10.1177/002215540004800203 1:CAS:528:DC%2BD3cXhsVGntbc%3D
65. AG Norden, et al. 2002 Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome J Am Soc Nephrol 13 1 125 133 11752029 1:CAS:528:DC%2BD38XltV2gsA%3D%3D (Pubitemid 34042019)
66. L Feliubadalo, et al. 1999 Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo, +AT) of rBAT Nat Genet 23 1 52 57 10471498 10.1038/12652 1:STN:280:DyaK1MvgtVGmsA%3D%3D (Pubitemid 29418787)
67. HA Simmonds 1986 2, 8-Dihydroxyadenine lithiasis Clin Chim Acta 160 2 103 108 3780004 10.1016/0009-8981(86)90129-4 1:CAS:528:DyaL2sXjtVOkuw%3D%3D (Pubitemid 17180010)
68. JA Tischfield FH Ruddle 1974 Assignment of the gene for adenine phosphoribosyltransferase to human chromosome 16 by mouse-human somatic cell hybridization Proc Natl Acad Sci USA 71 1 45 49 4129802 10.1073/pnas.71.1.45 1:CAS:528:DyaE2cXhtVKgurw%3D
69. TP Broderick, et al. 1987 Comparative anatomy of the human APRT gene and enzyme: nucleotide sequence divergence and conservation of a nonrandom CpG dinucleotide arrangement Proc Natl Acad Sci USA 84 10 3349 3353 3554238 10.1073/pnas.84.10.3349 1:CAS:528:DyaL2sXls12kt7o%3D (Pubitemid 17085401)
70. Sahota AS, Tischfield J, Kamatani N, Simmonds HA. Adenine phosphoribosyltransferase deficiency and 2,8-dihydroxyadenine lithiasis. In: Scriver CR et al., Editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001. p. 2571-84.
71. A Sahota, et al. 1991 Mutational basis of adenine phosphoribosyltransferase deficiency Adv Exp Med Biol 309B 73 76 1781410 1:CAS:528:DyaK38XkvVOqurs%3D
72. BS Gathof N Zollner 1992 The restriction enzyme Mse I applied for the detection of a possibly common mutation of the APRT locus Clin Investig 70 6 535 1392421 10.1007/BF00210238 1:CAS:528:DyaK3sXhvV2ht7s%3D
73. C Menardi, et al. 1997 Human APRT deficiency: indication for multiple origins of the most common Caucasian mutation and detection of a novel type of mutation involving intrastrand-templated repair Hum Mutat 10 3 251 255 9298830 10.1002/(SICI)1098-1004(1997)10:3<251::AID-HUMU15>3.0.CO;2-Z 1:CAS:528:DyaK2sXmtVOrtbY%3D (Pubitemid 27371688)
74. N Kamatani, et al. 1992 Only three mutations account for almost all defective alleles causing adenine phosphoribosyltransferase deficiency in Japanese patients J Clin Invest 90 1 130 135 1353080 10.1172/JCI115825 1:CAS:528:DyaK38XltV2gtb0%3D
75. L Deng, et al. 2001 2, 8-Dihydroxyadenine urolithiasis in a patient with considerable residual adenine phosphoribosyltransferase activity in cell extracts but with mutations in both copies of APRT Mol Genet Metab 72 3 260 264 11243733 10.1006/mgme.2000.3142 1:CAS:528:DC%2BD3MXhslSnu70%3D (Pubitemid 34171444)
76. C Scheid, et al. 2000 Oxalate-induced changes in renal epithelial cell function: role in stone disease Mol Urol 4 4 371 381 11156705 1:CAS:528:DC%2BD3MXlvVCg
77. Lieske JC, Deganello S. Nucleation, adhesion, and internalization of calcium-containing urinary crystals by renal cells. J Am Soc Nephrol. 1999;10(Suppl 14):S422-9. (Pubitemid 29498594)
78. AP Evan, et al. 2010 Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease Kidney Int 78 3 310 317 20428098 10.1038/ki.2010.131 1:CAS:528:DC%2BC3cXovFKgtLc%3D
79. AP Evan, et al. 2006 Renal crystal deposits and histopathology in patients with cystine stones Kidney Int 69 12 2227 2235 16710357 10.1038/sj.ki.5000268 1:CAS:528:DC%2BD28XlsVertro%3D (Pubitemid 43882110)
80. Harambat J, et al. Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int. 2010;77(5):443-9.
81. SR Khan 2011 Crystal/cell interaction and nephrolithiasis Arch Ital Urol Androl 83 1 1 5 21585160
82. DG Assimos, et al. 2002 The impact of cystinuria on renal function J Urol 168 1 27 30 12050485 10.1016/S0022-5347(05)64824-0 (Pubitemid 34640777)
83. M Arnadottir, et al. 1997 Acute renal failure in a middle-aged woman with 2, 8-dihydroxyadeninuria Nephrol Dial Transpl 12 9 1985 1987 10.1093/ndt/12.9.1985 1:STN:280:DyaK2svltFCjsQ%3D%3D (Pubitemid 27379478)
84. NJ Redhead, et al. 1996 Mice with adenine phosphoribosyltransferase deficiency develop fatal 2, 8-dihydroxyadenine lithiasis Hum Gene Ther 7 13 1491 1502 8864750 10.1089/hum.1996.7.13-1491 1:CAS:528:DyaK28Xls1Gnu7c%3D (Pubitemid 26302204)
85. Stockelman MG, et al. Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency. Am J Physiol. 1998;275(1 Pt 2):F154-63.
86. L Wang, et al. 2000 Altered gene expression in kidneys of mice with 2, 8-dihydroxyadenine nephrolithiasis Kidney Int 58 2 528 536 10916076 10.1046/j.1523-1755.2000.00199.x 1:CAS:528:DC%2BD3cXlvFahu7o%3D (Pubitemid 30620002)
87. AP Evan, et al. 2001 Sequential analysis of kidney stone formation in the Aprt knockout mouse Kidney Int 60 3 910 923 11532086 10.1046/j.1523-1755.2001. 060003910.x 1:STN:280:DC%2BD3MvpsFWhtA%3D%3D (Pubitemid 34205791)
88. CG Monico, et al. 2005 Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele Kidney Int 67 5 1704 1709 15840016 10.1111/j.1523-1755.2005.00267.x 1:CAS:528:DC%2BD2MXktlOqur8%3D (Pubitemid 40577704)
89. A Santana, et al. 2003 Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase Proc Natl Acad Sci USA 100 12 7277 7282 12777626 10.1073/pnas.1131968100 1:CAS:528:DC%2BD3sXkslOms7s%3D (Pubitemid 36706429)
90. E Leumann B Hoppe T Neuhaus 1993 Management of primary hyperoxaluria: efficacy of oral citrate administration Pediatr Nephrol 7 2 207 211 8476722 10.1007/BF00864405 1:STN:280:DyaK3s3jslSgug%3D%3D (Pubitemid 23093710)
91. Pey AL, Salido E, Sanchez-Ruiz JM. Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria. Amino Acids. 2010. (Epub ahead of print).
92. B Hoppe, et al. 2006 Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1 Kidney Int 70 7 1305 1311 16850020 10.1038/sj.ki.5001707 1:CAS:528:DC%2BD28Xpsl2qsb8%3D (Pubitemid 44435182)
93. Hoppe B, et al. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transplant. 2011. (Epub ahead of print).
94. V Cebotaru, et al. 2005 High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease Kidney Int 68 2 642 652 16014041 10.1111/j.1523-1755.2005.00442.x 1:CAS:528: DC%2BD2MXpt1Wmtrs%3D (Pubitemid 43323119)
95. JS Rodman, et al. 1984 The effect of dietary protein on cystine excretion in patients with cystinuria Clin Nephrol 22 6 273 278 6441658 1:STN:280:DyaL2M7isFCqsA%3D%3D (Pubitemid 15176729)
96. LM Rodriguez, et al. 1995 Effect of a low sodium diet on urinary elimination of cystine in cystinuric children Nephron 71 4 416 418 8587621 10.1159/000188761 1:STN:280:DyaK287lvF2jsA%3D%3D
97. F Barbey, et al. 2000 Medical treatment of cystinuria: critical reappraisal of long-term results J Urol 163 5 1419 1423 10751848 10.1016/S0022-5347(05)67633-1 1:CAS:528:DC%2BD3cXivFOhs7k%3D (Pubitemid 30226286)
98. CY Pak CJ Fuller 1983 Assessment of cystine solubility in urine and of heterogeneous nucleation J Urol 129 5 1066 1070 6854756 1:STN:280: DyaL3s3hs1elsg%3D%3D (Pubitemid 13100638)
99. DS Goldfarb FL Coe JR Asplin 2006 Urinary cystine excretion and capacity in patients with cystinuria Kidney Int 69 6 1041 1047 16501494 10.1038/sj.ki.5000104 1:CAS:528:DC%2BD28XitFGht7s%3D (Pubitemid 43372179)
100. Y Nakagawa, et al. 2000 Clinical use of cystine supersaturation measurements J Urol 164 5 1481 1485 11025687 10.1016/S0022-5347(05)67011-5 1:CAS:528:DC%2BD3cXnslCiu7g%3D
101. DJ Dolin, et al. 2005 Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria J Endourol 19 3 429 432 15865542 10.1089/end.2005.19.429 (Pubitemid 40656327)
102. Y Takano, et al. 2005 Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase Life Sci 76 16 1835 1847 15698861 10.1016/j.lfs.2004.10.031 1:CAS:528:DC%2BD2MXhtFGrt7s%3D (Pubitemid 40215224)
103. RL Wortmann 2005 Recent advances in the management of gout and hyperuricemia Curr Opin Rheumatol 17 3 319 324 15838244 10.1097/01.bor. 0000162060.25895.a5 1:CAS:528:DC%2BD2MXjtlKltbo%3D (Pubitemid 40616579)
104. A Gutierrez-Macias, et al. 2005 Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia BMJ 331 7517 623 624 16166134 10.1136/bmj.331.7517.623 (Pubitemid 41360781)
105. M Hatch RW Freel 2005 Intestinal transport of an obdurate anion: oxalate Urol Res 33 1 1 16 15565438 10.1007/s00240-004-0445-3 1:CAS:528: DC%2BD2MXitlOntLs%3D (Pubitemid 40487187)